Journal
PHARMACOLOGICAL RESEARCH
Volume 110, Issue -, Pages 131-138Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2016.05.018
Keywords
ncRNA; Cancer; Bioinformatics; Drug delivery; Apoptosis
Categories
Funding
- 'Assocazione Amici di URI (onlus)'
- 'Associazione Italiana per la Ricerca sul Cancro
Ask authors/readers for more resources
Thanks to impressive technology advancements, pervasive expression of non-coding RNAs (ncRNAs) has been recently identified in the genome of numerous cancers. Long ncRNAs (IncRNAs) belong to a new class of ncRNAs including tens of thousands different species. A fraction of these molecules shows a striking cancer-enriched expression pattern, suggesting an essential role in tumor cells and, possibly, a utility in therapeutic terms. This review aims at summarizing current knowledge for the identification and validation of IncRNAs as therapeutics targets in tumors. Both in-silico and wet-biology resources are presented in relation to the many challenges that the scientific community still needs to address in terms of IncRNA identification, stratification, patient personalization, drug delivery and toxicity. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available